Gilead

Rediff.com » News » Gilead

News for Gilead

News
Business
Sports

COVID-19: Remdesivir will be available from next week

Antiviral drug Remdesivir, approved by the United States food and regulatory body for emergency use to treat the COVID-19 patients, is expected to be available by next week, the chief executive......

Govt to import 4.5 lakh vials of Remdesivir amid Covid spike

The government has placed orders for import of 4.5 lakh vials of antiviral drug Remdesivir with the first consignment of 75,000 vials expected to reach Indian shores on Friday, Chemicals and......

India-made Remdesivir may come out in 10 days

The antiviral drug may cost around Rs 55,000 for an 11-dose course, or Rs 5,000 per injection -- much less than the price of imports from Bangladesh, reports Sohini Das. Image used for......

Antiviral drug shows promise for treating COVID-19

The phase three clinical trial of the antiviral drug remdesivir, led by a team of investigators including an Indian-American physician, for the treatment of the coronavirus patients has shown......

Remdesivir black-market thrives as Covid cases rise

Artificial shortages and brazen hawking of the drug on the streets at 15 times the normal price rule the day as the official machinery tries desperately to stamp out the parallel market, reports......

Natco challenges Gilead's patent on Tamiflu

Hyderabad-based Natco Pharma has challenged the patent for Tamiflu - a drug to treat bird flu - in the US.The company has sought the United States Food and Drug Administration (FDA)'s approval to......

3 generic HIV/AIDS drugs: Ranbaxy-Gilead pact

Drug major Ranbaxy said Tuesday it has entered into an agreement with US-headquartered Gilead Sciences to manufacture and market three new generic HIV/AIDS drugs in India and developing......

Gilead to allow 5 Indian firms to sell hepatitis generics in 90 countries

Multinational American drug maker Gilead Sciences was set to join hands with at least five Indian generic pharmaceutical companies and allow them to manufacture and sell cheaper versions of its new......

Gilead to offer multiple AIDS drug licences

US-based Gilead Sciences is scouting for partners to issue multiple 'manufacturing licences' for its AIDS drug, Tenofovir, in India and 97 other countries including those in Africa, the Caribbeans......

Sensex soars 997 points on gains in IT, banking stocks

ONGC was the top gainer in the Sensex pack, rallying over 13 per cent, followed by HCL Tech, Hero MotoCorp, NTPC, TCS, M&M, Infosys and Maruti. NSE Nifty soared 306.55 points, or 3.21 per cent, to......

Top doctor says Japan must keep state of emergency

'Without vaccine, Tokyo Olympics in 2021 is difficult' IMAGE: The Tokyo Games were postponed until 2021 last week as the coronavirus outbreak deepened, an unprecedented move in the 124-year......

Gilead

News for Gilead

COVID-19: Remdesivir will be available from next week

Govt to import 4.5 lakh vials of Remdesivir amid Covid spike

India-made Remdesivir may come out in 10 days

Antiviral drug shows promise for treating COVID-19

Remdesivir black-market thrives as Covid cases rise

Natco challenges Gilead's patent on Tamiflu

3 generic HIV/AIDS drugs: Ranbaxy-Gilead pact

Gilead to allow 5 Indian firms to sell hepatitis generics in 90 countries

Gilead to offer multiple AIDS drug licences

Sensex soars 997 points on gains in IT, banking stocks

Top doctor says Japan must keep state of emergency

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS